Literature DB >> 27386757

Physical therapy management of infants and children with hypophosphatasia.

Dawn Phillips1, Laura E Case2, Donna Griffin3, Kim Hamilton4, Sergio Lerma Lara5, Beth Leiro6, Jessica Monfreda7, Elaine Westlake8, Priya S Kishnani9.   

Abstract

Hypophosphatasia (HPP) is a rare inborn error of metabolism resulting in undermineralization of bone and subsequent skeletal abnormalities. The natural history of HPP is characterized by rickets and osteomalacia, increased propensity for bone fracture, early loss of teeth in childhood, and muscle weakness. There is a wide heterogeneity in disease presentation, and the functional impact of the disease can vary from perinatal death to gait abnormalities. Recent clinical trials of enzyme replacement therapy have begun to offer an opportunity for improvement in survival and function. The role of physical therapy in the treatment of the underlying musculoskeletal dysfunction in HPP is underrecognized. It is important for physical therapists to understand the disease characteristics of the natural history of a rare disease like HPP and how the impairment and activity limitations may change in response to medical interventions. An understanding of when and how to intervene is also important in order to optimally impact body function, lessen structural impairment, and facilitate increased functional independence in mobility and activities of daily living. Individualizing treatment to the child's needs, medical fragility, and setting (home/school/hospital), while educating parents, caregivers, and school staff regarding approved activities and therapy frequency, may improve function and development in children with HPP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fractures, spontaneous; Gait; Hypophosphatasia; Motor skills; Musculoskeletal pain; Physical therapy specialty

Mesh:

Year:  2016        PMID: 27386757     DOI: 10.1016/j.ymgme.2016.06.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

1.  Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.

Authors:  T Schmidt; H Mussawy; T Rolvien; T Hawellek; J Hubert; W Rüther; M Amling; F Barvencik
Journal:  Osteoporos Int       Date:  2017-05-25       Impact factor: 4.507

Review 2.  Muscle-Bone Interactions in Pediatric Bone Diseases.

Authors:  Louis-Nicolas Veilleux; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 3.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Proximal iliotibial band thickness as a cause for recalcitrant greater trochanteric pain syndrome.

Authors:  Anthony N Khoury; Karina Brooke; Asad Helal; Benton Bishop; Lane Erickson; Ian James Palmer; Hal David Martin
Journal:  J Hip Preserv Surg       Date:  2018-08-08

Review 5.  Childhood hypophosphatasia: to treat or not to treat.

Authors:  Eric T Rush
Journal:  Orphanet J Rare Dis       Date:  2018-07-16       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.